Underdiagnosis of primary immunodeficiency disorders among racial and ethnic minorities: Recognize and Educate09/19/2022 - 05/31/2027 (Subcontract PI)
Harvard Pilgrim Health Care Inc NIH NIMHD1R01MD017816-01
Define Gender-Specific Modifiers of Immune Predisposition to Long-haul COVID-1903/19/2024 - 06/30/2025 (Subcontract PI)
Lahey Clinic, Inc. MA Life Sciences Ctr
Kayla Bell Lecture on Primary Immunodeficiency Diseases04/24/2024 - 04/24/2024 (PI)
Takeda Development Center Americas, Inc.
How B cell developmental defects shape manifestations of common variable immunodeficiency07/01/2019 - 06/30/2023 (PI)
American Academy of Allergy, Asthma, and Immunology
Immunomodulatory role of IgG replacement therapy in common variable immunodeficiency04/29/2019 - 04/29/2023 (PI)
Shire, Inc.
Role of B cell activating factor in non-infectious complications of common variable immunodeficiency02/01/2019 - 01/31/2023 (PI)
NIH/National Institute of Allergy & Infectious Diseases5K23AI137183-05
Kayla Bell Lecture on Primary Immunodeficiency Disease07/16/2021 - 06/30/2022 (PI)
Takeda Pharmaceuticals North America, Inc.
Optimizing efficacy of interferon-y therapy in primary immunodeficiency patients05/09/2019 - 05/09/2022 (PI)
Horizon Pharma USA
Mechanisms of immune dysregulation due to NFKB1 mutation in common variable immunodeficiency03/01/2020 - 02/28/2022 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R21AI151486-02
B cell maturation antigen in the diagnosis and management of antibody deficiency09/01/2020 - 09/01/2021 (PI)
Immune Deficiency Foundation Inc.
Identifying B cell maturation defects that shape manifestations of common variable immunodeficiency07/01/2019 - 06/30/2022 (PI)
American Academy of Allergy, Asthma, and Immunology